News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
260 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17699)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Therma Bright’s AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration’s Emergency Use Authorization Requirements
This achievement places Therma Bright in a very unique leadership position as the first company in the COVID-19 diagnostic testing space to successfully complete a 15-minute rapid antigen saliva-based U.S. study.
February 15, 2022
·
6 min read
Oncoinvent to Participate in Upcoming Virtual Investor Conferences - Feb 15, 2022
Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced that members of management will participate in two upcoming virtual investor conferences.
February 15, 2022
·
1 min read
Business
Tachyum and Barcelona Supercomputing Center Sign Memorandum of Understanding for Collaboration
Tachyum™ today announced it has entered into a MOU with the Barcelona Supercomputing Center (BSC) in Spain with the intent to collaborate on open supercomputing projects, scientific research, and innovations in AI.
February 15, 2022
·
4 min read
Brachytherapy Afterloaders Market: Prostate Cancer to be Most Attractive Segment of Global Market
Brachytherapy is a procedure that involves placing a radioactive material inside the body. It is a type of radiotherapy used to treat cancer. It is sometimes called internal radiation.
February 15, 2022
·
6 min read
CNS Therapeutics Market: Rise in the awareness about CNS therapeutics diseases to drive the market
Central nervous system (CNS) is an integral part of the nervous system that comprises brain and spinal cord.
February 15, 2022
·
5 min read
Comprehensive Metabolic Panel (CMP) Testing Market: Kidney Tests Segment Dominated Global Market
Comprehensive metabolic panel (CMP) testing is a blood test that measures body’s fluid balance and electrolyte levels and tests functions of kidney and liver.
February 15, 2022
·
14 min read
Sick Sinus Syndrome Treatment Market: Rise in Incidence of Heart Related Diseases to Drive the Market
Sick sinus syndrome is a group disorder including three heart rhythm problems (arrhythmias): sinus bradycardia (a slow heart rate), tachycardias (fast heart rates), and bradycardia-tachycardia (alternating slow and fast heart rhythms).
February 15, 2022
·
5 min read
Tauopathies Treatment Market: Rise in incidence of neurodegenerative diseases to drive the market
As per the NCBI (National Center for Biotechnology Information), tauopathies are described as neurodegenerative disorders caused by abnormal deposition of tau protein in the brain.
February 15, 2022
·
5 min read
FDA
Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure
Cardiosense, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device status for its novel algorithm to identify patients at risk of decompensated heart failure.
February 15, 2022
·
4 min read
Vision Screeners Market Growth Drivers and Global Development Analysis Report
The demand within the global vision screeners market is growing on account of improvements in ophthalmological testing.
February 15, 2022
·
5 min read
Previous
10 of 26
Next